1987
DOI: 10.1097/00006254-198742050-00008
|View full text |Cite
|
Sign up to set email alerts
|

Prospective Study of Pregnancy in Systemic Lupus Erythematosus. Results of a Multidisciplinary Approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
98
3
8

Year Published

1990
1990
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 109 publications
(116 citation statements)
references
References 0 publications
7
98
3
8
Order By: Relevance
“…Although controversial, several prospective studies have shown increased disease activity during pregnancy, ranging from 30% to 70% [20][21][22][23]. The risk of lupus flares is higher if the woman has had active disease in the 6 months prior to pregnancy [1].…”
Section: Discussionmentioning
confidence: 99%
“…Although controversial, several prospective studies have shown increased disease activity during pregnancy, ranging from 30% to 70% [20][21][22][23]. The risk of lupus flares is higher if the woman has had active disease in the 6 months prior to pregnancy [1].…”
Section: Discussionmentioning
confidence: 99%
“…18,24 Lupus nephritis flare Studies from 1970 through 1992 have included 276 women who had a diagnosis of lupus nephritis pre-pregnancy; 133 (48%) had an exacerbation of renal disease during pregnancy, with many developing nephrotic-range proteinuria. [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] However, a more recent multi-centre retrospective study reporting renal and pregnancy outcomes of 113 pregnancies in 81 women with lupus nephritis found renal flare affected only 15% of pregnancies and in 15% of women up to a year post-partum. 42 Flares were more common in women with active disease pre-pregnancy, in partial remission, those with proteinuria >1 g/24 hours or with a glomerular filtration rate (GFR) <60 ml/min/1.73 m 2 .…”
Section: Disease Activity During Pregnancymentioning
confidence: 99%
“…Fetal adrenal suppression is rare [99]. Intrauterine growth retardation with CS use during pregnancy has not been reported in several studies [94,100] and in others may be a reflection of the underlying maternal disease [101].…”
Section: Corticosteroidsmentioning
confidence: 99%